Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amylyx Pharmaceuticals, Inc. - Common Stock
(NQ:
AMLX
)
2.200
+0.070 (+3.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amylyx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Amylyx Pharmaceuticals Completes Negotiation Process and Signs Letter of Intent with the pCPA for ALBRIOZA™ for the Treatment of ALS
June 15, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?
June 13, 2023
Which of these red-hot biotech stocks is the better buy right now?
Via
The Motley Fool
Amylyx Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
7 Analysts Have This to Say About Amylyx Pharma
May 31, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Amylyx Pharma
May 15, 2023
Via
Benzinga
Analyst Expectations for Amylyx Pharma's Future
May 15, 2023
Via
Benzinga
Amylyx Pharma Earnings Preview
May 10, 2023
Via
Benzinga
Analyst Ratings for Amylyx Pharma
March 31, 2023
Via
Benzinga
How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run
June 01, 2023
Shares surged into and out of the company's R&D Day, which included a surprise.
Via
Investor's Business Daily
Amylyx Pharmaceuticals Provides Update on Ongoing Regulatory Review of AMX0035 for the Treatment of ALS in the European Union
May 30, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals Turns Profitable On Successful Drug Launch
May 16, 2023
Amylyx Pharmaceuticals is the rare young biotech that's profitable. The company earned $0.02 a share in Q1, and analysts expect profitability to grow.
Via
MarketBeat
2 Supercharged Growth Stocks to Buy Right Now
May 14, 2023
These two biopharma stocks might be poised for a major breakout.
Via
The Motley Fool
Expert Ratings for Amylyx Pharma
March 31, 2023
Via
Benzinga
Looking Into Amylyx Pharmaceuticals's Return On Capital Employed
March 15, 2023
Via
Benzinga
Analyst Expectations for Amylyx Pharma's Future
March 14, 2023
Via
Benzinga
Why Amylyx Pharmaceuticals Stock Is Bolting Higher Today
March 14, 2023
The biopharma's new ALS drug is exceeding projections on the sales front.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 12, 2023
Via
Benzinga
US Stock Futures Signal Strong Finish To Wobbly Week — But Analyst Still Sees Recession Risk On Horizon
May 12, 2023
Via
Benzinga
Amylyx Blows Past Sales Expectations, Reports Unexpected Profit — Shares Rocket
May 11, 2023
The company was expected to post another loss, but instead came in with a gain of 2 cents per share.
Via
Investor's Business Daily
Amylyx Pharmaceuticals Reports First Quarter 2023 Financial Results
May 11, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023
May 05, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
Biotech is expected to be a hotbed of mergers and acquisitions this year.
Via
The Motley Fool
Amylyx Pharmaceuticals Appoints Masako Nakamura to General Manager and Head of International Markets - Asia Pacific and Latin America
April 20, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 2 Study of AMX0035 for the Treatment of Wolfram Syndrome
April 13, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals - An Emerging Leader In ALS
April 12, 2023
Amylyx has sold off from its earnings report on March 13th. What has been driving this move and what does it mean for the long term prospects of Amylyx?
Via
Talk Markets
Amylyx Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
7 Biotech Stocks to Buy for 100% Returns
April 09, 2023
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
March 31, 2023
Via
Benzinga
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
March 17, 2023
A market rally is underway, but bank stocks kept tumbling.
Via
Investor's Business Daily
Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.